FGFR2 and breast carcinoma: In addition, as FGFR2 has been shown to be overexpressed or amplified only in a small percentage of breast cancers [9],[10],[24], it is possible that the association with breast cancer risk could be stronger and more clinically relevant for the small subset of tumors that express high levels of the receptor.